UNI-PHARMA
UNI-PHARMA is a privately held Greek pharmaceutical manufacturer founded in 1963, producing prescription medicines, OTC drugs, patented food supplements, and medical devices under GMP standards for domestic and international B2B customers including the UN, UNICEF, and WHO.
- Company typePrivate
- Founded1963
- HeadquartersThessaloníki, Greece
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What UNI-PHARMA does
UNI-PHARMA Kleon Tsetis Pharmaceutical Laboratories S.A. is a privately held Greek pharmaceutical manufacturer founded in 1963 by pharmacist Kleonas Tsetis and now led by his daughter Julia Tsetis as President and CEO. The company researches, develops, produces, and markets a broad portfolio of prescription medicines (e.g., T4, Salospir Trebon), OTC products (e.g., Apotel, Trebon Grippe day & night), patented food supplements (Hepatrat, TONOSAN, Lactolevure Cran), medical devices, dermocosmetics, and herbal/natural products via its UniHerbo subsidiary. Manufacturing is anchored in a GMP-certified bioclimatic factory in Kifissia operational since 2015, supported by robotic production systems, a renovated historic facility on the Athens-Lamia National Road, and a new warehouse — collectively representing the largest capital deployment in the Greek pharmaceutical sector over the last decade (€120M+).
The company operates a B2B, sales-led go-to-market, distributing through Greek pharmacy networks via a field force of medical representatives targeting healthcare professionals, while exporting internationally through active participation at Vitafoods Europe, WHX Dubai, Arab-Hellenic Health Conference, and AEEDC Dubai. UNI-PHARMA and its sister company InterMed are official suppliers to the UN, UNICEF, and WHO. Research is conducted in collaboration with Greek academic institutions, including Aristotle University of Thessaloniki and the National and Kapodistrian University of Athens, with 45+ internal research programs since 2018 and 10 co-funded national/international programs under the General Secretariat for Research and Innovation. Revenue mechanics flow through prescription recurring volume for Rx products, one-time unit sales for OTC, supplements, and medical devices, and direct institutional contracts with international organizations — pricing is regulated by national pharmaceutical frameworks and not publicly disclosed.
UNI-PHARMA firmographics
Firmographics- Name
- UNI-PHARMA
- Legal name
- UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A.
- Website
- https://uni-pharma.gr
- Company type
- Private
- Founded year
- 1963
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- UNI-PHARMA is a privately held Greek pharmaceutical manufacturer founded in 1963, producing prescription medicines, OTC drugs, patented food supplements, and medical devices under GMP standards for domestic and international B2B customers including the UN, UNICEF, and WHO.
- Ownership category
- akta.pro rank
UNI-PHARMA industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)
Keywords
Where UNI-PHARMA is headquartered
LocationHeadquarters
- HQ city
- Thessaloníki
- HQ country
- Greece
- HQ region
- Europe
Offices2 records
Markets served
UNI-PHARMA business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Prescription Medicines: Pharmaceutical products requiring medical prescription including branded medications such as T4, Apotel, Salospir, Trebon, and Trebon Grippe day & night
- Non-Prescription (OTC) Medicines: Over-the-counter pharmaceutical products available without prescription
- Food Supplements: Dietary supplements including vitamins, probiotics, joint health products, immune support, and gastrointestinal health products such as Lactolevure Cran, Hepatrat, and TONOSAN
- Medical Devices: Medical device products for healthcare applications
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
UNI-PHARMA product offering
Product offeringCore offering
UNI-PHARMA researches, develops, manufactures, and markets a diversified portfolio of pharmaceutical products under high GMP standards. Its offerings span branded prescription medicines (T4, Apotel, Salospir Trebon, Trebon Grippe day & night), over-the-counter medicines, food supplements (Hepatrat, TONOSAN Men's LBD Boost, Lactolevure Cran), medical devices, dermocosmetics, oral-care products, antimosquito/antiviral products, and selected food items, serving healthcare professionals, pharmacies, and institutional customers domestically and internationally.
Product overview
UNI-PHARMA is a Greek pharmaceutical company that manufactures and markets a diverse portfolio of pharmaceutical products and dietary supplements. The product portfolio includes prescription and non-prescription medicines (such as T4, Apotel, Salospir Trebon, Trebon Grippe day & night), medical devices, food supplements (including probiotics, vitamins, and supplements for joint/bone health, immune support, and gastrointestinal function), dermocosmetics, oral cavity products, and antimosquito products. The company operates under GMP standards and has invested significantly in research and innovation, developing patented products like Hepatrat and TONOSAN.
Differentiator
Problem solved
Functional benefit
Brands
- Lactolevure Cran: Cranberry-probiotic-vitamin C dietary supplement product marketed by UNI-PHARMA for UTI prevention in children.
Products and services
- Lactolevure Cran Cranberry-probiotic-vitamin C dietary supplement containing 36 mg PACs from cranberry, 6 billion CFUs of Lactobacillus rhamnosus and Bifidobacterium longum, and 250 mg vitamin C; clinically studied for reducing UTIs in pediatric patients.
- T4 Thyroid medication (levothyroxine) included in UNI-PHARMA's portfolio of pioneering pharmaceutical preparations.
- Apotel Over-the-counter analgesic and antipyretic medication available without prescription.
- Salospir Trebon Non-prescription medication included in UNI-PHARMA's pharmaceutical product portfolio.
- Trebon Grippe day & night Day and night cold/flu medication formulation from UNI-PHARMA's pharmaceutical portfolio.
- Hepatrat Innovative dietary supplement in a bilayer tablet formulation with European Patent (EP4181693B1) for patients with fatty liver disease.
- TONOSAN Men's LBD Boost Patented men's health formulation designed to support men's wellbeing and Libido (LBD) boost.
- Medical Devices Medical device products manufactured or distributed by UNI-PHARMA for healthcare applications.
- Skin Cosmetics (Dermocosmetics) Skincare and cosmetic (dermocosmetic) products manufactured by UNI-PHARMA.
- Oral Cavity Products Oral cavity and dental health products manufactured by UNI-PHARMA.
- Antimosquito & Antiviral Products Antimosquito and antiviral topical and consumer health products.
Quantifiable outcome
- Nearly 70% of children had no UTI infections during follow-up period in clinical study of Lactolevure Cran
Companies that use UNI-PHARMA
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
UNI-PHARMA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
UNI-PHARMA partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor and core.
- Grant Thornton & EurobankminorAward recognition: UNI-PHARMA named Growth Winner among 6 top companies from 8,000 assessed for significant development footprint and export orientation.
- InterMedcoreInterMed is part of the Tsetis Pharmaceutical Group alongside UNI-PHARMA. Both companies are internationally recognized as official suppliers to UN, UNICEF, and WHO. InterMed participated at AEEDC Dubai with scientific presentations on dental implants and both companies participate together at international exhibitions like Vitafoods Europe.
- Aristotle University of ThessalonikicoreResearchers at Aristotle University conducted a prospective clinical study evaluating UNI-PHARMA's Lactolevure Cran cranberry-probiotic-vitamin C supplement on 39 children with recurrent UTIs, finding nearly 70% had no infections during follow-up.
- Greek Academic and Research InstitutionscoreUNI-PHARMA executes over 45 internal research programs in collaboration with Greek Academic and Research Institutions since 2018. The company also participates as industrial partner in 10 national/international research programs co-funded through the General Secretariat for Research and Innovation.
- Kleon Tsetis Foundation (AMKE)coreThe non-profit foundation established by the Tsetis family has funded 30 research programs through scholarships and grants, supports NKUA Cardiology Clinics with academic scholarships, and established scholarships in memory of Garifallia Psarrakou for Pharmacy department research.
- National and Kapodistrian University of Athens (NKUA)coreNKUA is a key academic partner for research collaborations. UNI-PHARMA donated 106 defibrillators to NKUA in memory of Professor Ioanna Andreadou. The Kleon Tsetis Foundation provides scholarships and research support to NKUA's Department of Pharmacy and Cardiology Clinics.
- UN Global CompactminorUNI-PHARMA and InterMed are proud members of UN Global Compact, supporting its 10 principles including climate action, anti-corruption, and sustainable development.
Scale indicators9 records
Recent moves10 records
Expansion highlights6 records
UNI-PHARMA competitors and assessment
Company assessmentDirect peers
- ELPEN Pharmaceutical: Greek pharmaceutical manufacturer founded in 1965 with prescription, OTC, and consumer health portfolios, and an established export network — the closest comparable mid-sized Greek pharma producer.
- Demo SA: Greece's largest domestic pharmaceutical manufacturer producing branded generics and specialty products with strong Greek retail pharmacy penetration and growing exports.
- Vianex SA: Long-established Greek pharmaceutical manufacturer (founded 1928) with branded prescription medicines, hospital injectables, and consumer health — directly comparable portfolio breadth and Greek-centric distribution model.
- Help Pharmaceuticals: Greek contract development and pharmaceutical manufacturer supplying prescription generics and OTC products domestically and abroad; comparable in scale, GMP operations, and route-to-market.
- Lavipharm: Greek pharmaceutical and personal-care manufacturer with consumer health, OTC, and dermo-cosmetic lines sold through domestic pharmacy distribution — overlapping UNI-PHARMA's food supplement and dermo-cosmetic verticals.
- Faran SA: Greek pharmaceutical manufacturer producing generics, OTC, and food supplements with Greek retail-pharmacy focus — directly comparable footprint and category mix.
Broad incumbents
- Catalent: Global pharmaceutical development and contract manufacturing organisation operating at massively larger scale; relevant as a benchmark for UNI-PHARMA's CDMO ambitions and as a competing bidder on European institutional tenders.
- Aenova Group: One of Europe's largest CDMOs with broad manufacturing capabilities for pharma and consumer health; useful overlap for UNI-PHARMA's potential CDMO contract business and international benchmark.
- Perrigo Company: Large multinational consumer self-care and OTC pharmaceutical company; competitive overlap with UNI-PHARMA's OTC and supplement portfolio in European and international pharmacy channels.
- Bayer Consumer Health: Global OTC and consumer health division of Bayer AG; competes head-to-head with UNI-PHARMA in food supplement and OTC categories across international pharmacy distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
UNI-PHARMA social profiles
Digital presenceUNI-PHARMA compliance and trust
Trust signalCompliance1 record
UNI-PHARMA financial estimates
Financial estimateRevenue estimate
Valuation estimate
UNI-PHARMA leadership team
Management profileNumber of profiles
Profiles2 records
UNI-PHARMA subsidiaries and ownership
Company hierarchySubsidiaries2 records
UNI-PHARMA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UNI-PHARMA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UNI-PHARMA
What does UNI-PHARMA do?
UNI-PHARMA researches, develops, manufactures, and markets a diversified portfolio of pharmaceutical products under high GMP standards. Its offerings span branded prescription medicines (T4, Apotel, Salospir Trebon, Trebon Grippe day & night), over-the-counter medicines, food supplements (Hepatrat, TONOSAN Men's LBD Boost, Lactolevure Cran), medical devices, dermocosmetics, oral-care products, antimosquito/antiviral products, and selected food items, serving healthcare professionals, pharmacies, and institutional customers domestically and internationally.
Is UNI-PHARMA a public or private company?
UNI-PHARMA is a private company. It is classified as family owned and is currently operating.
When was UNI-PHARMA founded?
UNI-PHARMA was founded in 1963. It employs 251 to 500 people.
Where is UNI-PHARMA based?
UNI-PHARMA is headquartered in Thessaloníki, Greece, in the Europe region.
How does UNI-PHARMA make money?
Four revenue lines are on record. Prescription Medicines are the primary driver. The others are non-Prescription (OTC) Medicines, food Supplements and medical Devices.
Who are UNI-PHARMA's main competitors?
Direct peers on record are ELPEN Pharmaceutical, Demo SA, Vianex SA, Help Pharmaceuticals, Lavipharm and Faran SA. Broad incumbents are Catalent, Aenova Group, Perrigo Company and Bayer Consumer Health.
Does UNI-PHARMA have an API?
No public API is recorded for UNI-PHARMA.
What industry is UNI-PHARMA in?
UNI-PHARMA's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.